These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414. Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252 [TBL] [Abstract][Full Text] [Related]
43. Studies on a new antiallergic pyridinecarboxamide TA-5707F and its sodium salt (TA-5707). I. Inhibition of IgE-induced passive cutaneous anaphylaxis (PCA) in rats. Tsuzurahara K; Murata T; Ishikawa S; Date T; Takeyama S Jpn J Pharmacol; 1986 Jan; 40(1):37-46. PubMed ID: 2937947 [TBL] [Abstract][Full Text] [Related]
44. Anti-allergic activities of a new benzopyranopyridine derivative Y-12,141 in rats. Goto K; Terasawa M; Maruyama Y Int Arch Allergy Appl Immunol; 1979; 59(1):13-9. PubMed ID: 87373 [TBL] [Abstract][Full Text] [Related]
45. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Leonardi A; Borghesan F; Avarello A; Plebani M; Secchi AG Br J Ophthalmol; 1997 Jan; 81(1):23-6. PubMed ID: 9135403 [TBL] [Abstract][Full Text] [Related]
46. Pyrrole, furan, and thiophene oxamates as potential antiallergy agents. Briggs FH; Pelletier WT; Blanton CD J Pharm Sci; 1978 May; 67(5):735-7. PubMed ID: 641827 [TBL] [Abstract][Full Text] [Related]
47. Disodium cromoglycate and inhibition of passive cutaneous anaphylaxis. Ankier SI Int Arch Allergy Appl Immunol; 1971; 41(1):161-2. PubMed ID: 4997944 [No Abstract] [Full Text] [Related]
48. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis. Avunduk AM; Avunduk MC; Kapicioglu Z; Akyol N; Tavli L Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862 [TBL] [Abstract][Full Text] [Related]
53. Anti-allergic properties of ethyl-3-methoxyphenyl-4-thiazolyl-2-oxamate (F 1865). Tarayre JP; Lauressergues H; Fauran F Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):165-76. PubMed ID: 6187305 [TBL] [Abstract][Full Text] [Related]
54. Disodium cromoglycate may act as a novel adjuvant for UV-attenuated Toxoplasma gondii vaccine in mouse model. Li X; Wu Y; Huang S; Lu F Parasitol Int; 2018 Jun; 67(3):351-356. PubMed ID: 29421521 [TBL] [Abstract][Full Text] [Related]
55. [Effect of predosing with Y-12,141 on its antiallergic activity. --Studies on anti-allergic agents(IV)-- (author's transl)]. Goto K; Terasawa M; Komori A; Maruyama Y Nihon Yakurigaku Zasshi; 1981 Feb; 77(2):123-9. PubMed ID: 6786963 [TBL] [Abstract][Full Text] [Related]
56. Effect of disodium cromoglycate on cutaneous basophil anaphylaxis. Golden HW; Crean GL; Iacuzio DA; Otterness IG J Immunol; 1986 Sep; 137(5):1495-503. PubMed ID: 2427571 [TBL] [Abstract][Full Text] [Related]
57. Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats. Yanni JM; Weimer LK; Glaser RL; Lang LS; Robertson SM; Spellman JM Int Arch Allergy Immunol; 1993; 101(1):102-6. PubMed ID: 7684628 [TBL] [Abstract][Full Text] [Related]
58. The effect of disodium cromoglycate and PGF2 alpha on acute cutaneous reactions of the guinea pig and rat. Taylor WA Int Arch Allergy Appl Immunol; 1973; 45(1):82-3. PubMed ID: 4199407 [No Abstract] [Full Text] [Related]
59. Disodium cromoglycate in anaphylaxis and pollinois. Goodman ML; Irwin JW Ann Allergy; 1978 Mar; 40(3):177-80. PubMed ID: 416732 [TBL] [Abstract][Full Text] [Related]
60. Peritoneal anaphylaxis in the rat after sensitization with mouse antiserum. Spicer BA; Ross JW; Sharpe TJ; Smith H Int Arch Allergy Appl Immunol; 1978; 56(6):493-9. PubMed ID: 415988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]